LHC Group (LHCG) Shares Bought by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP grew its stake in LHC Group (NASDAQ:LHCG) by 1.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,275,663 shares of the health services provider’s stock after purchasing an additional 13,347 shares during the period. Dimensional Fund Advisors LP owned about 7.19% of LHC Group worth $86,604,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently bought and sold shares of LHCG. Federated Investors Inc. PA boosted its stake in shares of LHC Group by 4.2% in the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after purchasing an additional 66 shares in the last quarter. Acrospire Investment Management LLC boosted its stake in shares of LHC Group by 30.8% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $115,000 after purchasing an additional 400 shares in the last quarter. Invictus RG acquired a new stake in shares of LHC Group in the 1st quarter valued at approximately $125,000. US Bancorp DE boosted its stake in shares of LHC Group by 25.1% in the 1st quarter. US Bancorp DE now owns 2,683 shares of the health services provider’s stock valued at $145,000 after purchasing an additional 539 shares in the last quarter. Finally, First Mercantile Trust Co. acquired a new stake in shares of LHC Group in the 2nd quarter valued at approximately $147,000. Institutional investors own 85.93% of the company’s stock.
LHC Group (NASDAQ LHCG) opened at 70.82 on Friday. The company has a market cap of $1.29 billion, a price-to-earnings ratio of 31.34 and a beta of 0.76. The firm’s 50-day moving average is $65.96 and its 200 day moving average is $61.50. LHC Group has a 12-month low of $32.04 and a 12-month high of $73.85.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. The firm had revenue of $260.20 million during the quarter, compared to analyst estimates of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The business’s quarterly revenue was up 15.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.52 earnings per share. On average, equities analysts expect that LHC Group will post $2.39 earnings per share for the current fiscal year.
A number of equities research analysts have recently weighed in on LHCG shares. Zacks Investment Research downgraded shares of LHC Group from a “buy” rating to a “hold” rating in a research note on Thursday, July 6th. Royal Bank Of Canada reiterated a “buy” rating and set a $69.00 target price on shares of LHC Group in a research report on Tuesday, July 18th. BidaskClub downgraded shares of LHC Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 12th. Robert W. Baird reiterated a “hold” rating and set a $63.00 target price on shares of LHC Group in a research report on Tuesday, September 12th. Finally, Jefferies Group LLC reiterated a “buy” rating and set a $68.00 target price on shares of LHC Group in a research report on Friday, August 4th. Two investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $66.60.
COPYRIGHT VIOLATION NOTICE: This piece was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another site, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The legal version of this piece can be viewed at https://www.thecerbatgem.com/2017/10/06/lhc-group-lhcg-shares-bought-by-dimensional-fund-advisors-lp.html.
In other news, COO Donald Dwayne Stelly sold 2,650 shares of the stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the sale, the chief operating officer now owns 109,235 shares of the company’s stock, valued at $7,137,414.90. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 14.80% of the company’s stock.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group (NASDAQ:LHCG).
Receive News & Stock Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related stocks with our FREE daily email newsletter.